🇺🇸 FDA
Pipeline program

D/ChAd63-CA

S-14-07

Phase 1 mab completed

Quick answer

D/ChAd63-CA for Malaria is a Phase 1 program (mab) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Malaria
Phase
Phase 1
Modality
mab
Status
completed

Clinical trials